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Lovastatin was used to study the role of isoprenylated GTP-binding proteins in the regulation of intracellular pH in granulocytic HL-60 cells. The 
cytosolic acidification that accompanies timulation by chemoattractants was completely eliminated by lovastatin. The subsequent activation of 
Na’lH’ exchange was partially inhibited by the isoprenylation antagonist. In contrast, the osmotic activation of the Na’/H’ antiport was unaffected. 
The data indicate that the osmotically- and receptor-induced activation of the antiport utilize divergent signalling pathways. The results also provide 
evidence supporting the notion that cytosolic acidification by chemoattractants results from accumulation of metabolic acid generated uring the 
respiratory burst. 
Na’lH’ exchange; Antiport; NADPH oxidase; Lovastatin; HL-60 cell 
1. INTRODUCTION 
Superoxide production is a vital mechanism whereby 
granulocytes protect the host from microbial infection. 
NADPH oxidase, the enzyme responsible for superox- 
ide generation, can also be activated in vitro by addition 
of synthetic chemotactic peptides [l]. Protons, a bypro- 
duct of the oxidase reaction, tend to accumulate in the 
cytosol during the respiratory burst. This tendency is 
effectively counteracted by pH regulatory mechanisms, 
including Na’/H’ exchange [2,3]. It is thought that che- 
motactic peptides activate the Na’/H’ antiporter di- 
rectly by shifting its affinity for intracellular H’ [2,3]. 
However, the molecular details of this stimulation are 
poorly understood. 
The antiporter can also be activated osmotically, 
when cells shrink in hypertonic solutions [4]. As in the 
case of receptor-mediated activation, the stimulatory 
process is incompletely understood. However, recent 
evidence obtained in muscle cells from invertebrates 
suggested that GTP-binding proteins may be involved 
1% 
A number of small molecular weight GTP-binding 
proteins, as well as the y-subunit of heterotrimeric G 
proteins undergo post-translational processing by iso- 
prenylation [6]. This modification alters the solubility of 
the GTP-binding proteins and appears to be essential 
for their role in signal transduction. To assess the role 
of isoprenylated proteins in pH, regulation in granulo- 
cytes we have used lovastatin, an agent reported to 
inhibit the activity of hydroxymethylglutaryl CoA re- 
ductase, the enzyme responsible for biosynthesis of me- 
valonate, which is the substrate for protein isoprenyla- 
tion [7]. The comparatively long incubations required 
for lovastatin to exert its effect precluded the use of 
blood neutrophils for these studies. Instead, we utilized 
the promyelocytic cell line HL-60. These cells, which 
grow in an undifferentiated state, cease to proliferate 
and undergo granulocytic differentiation developing a 
fully activatable NADPH oxidase when treated with 
dimethyl sulfoxide [8,9]. By inhibiting isoprenylation in 
these cells, we obtained evidence that different pathways 
mediate the osmotic and receptor-induced activation of 
the antiport. In addition, the data provide further evi- 
dence that the respiratory burst is the main source of 
cytosolic acidification during neutrophil activation. 
2. MATERIALS AND METHODS 
2.1. Reagents and solutrons 
Formyl-methionyl-leucyl-phenylalanine (FMLP) and mevalonic 
acid were from Sigma. RPMI-1640 medium was purchased from 
Gibco. Nigericin was from Calbiochem-Behring. 2,7-Biscarboxyethyl- 
5(6)-carboxyfluorescein (BCECF) acetoxymethyl ester was obtained 
from Molecular Probes. N-Methyl-N-(2-methyl-2-propenyl-amino) 
amiloride (MMPA) was the kind gift of Merck, Sharp and Dohme. 
Lovastatin was the generous gift of Dr. A. Prat (Merck Frosst, 
Montreal). The Na+-solution contained (in mM): 140 NaCI, 
4 KCl, 1 CaCI,, 1 MgCl,, 5 glucose, and 10 A’-2-hydroxyeth-ylpiper- 
azine-N-2-ethanesulfonic acid (HEPES), pH 7.3 at 37°C (300 f 10 
mosM). 
*Corresponding author. Fax: (1) (416) 813 5028. 2.2. Culture of HL-60 cells 
HL-60 cells were cultured in RPM1 1640 medium containing 10% 
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were treated with lovastatin by addition of a 16-fold concentrated 
stock solution to a final concentration of 3.5 ,uM on day 4 of differen- 
tiation. In order to study the effect of mevalonic acid, the compound 
was added to the cell culture as the mevalonolactone at a concentra- 
tion of 1 mM on day 4 of differentiation. 
2.3. Cyroplasmic pH measurements 
Cytoplasmic pH was determined fluorimetrically using intact differ- 
entiated HL-60 cells, essentially as described earlier for human neutro- 
phils [lo]. Cells (lO’/ml) were loaded with the probe BCECF by incu- 
bation with the parent acetoxymethyl ester (3 ,&ml, final) for 10 min 
at 37°C. After washing, 2.5 x lo6 cells were used for fluorescence 
measurement with excitation at 495 nm and emission at 525 nm using 
5- and IO-nm slits, respectively. Calibration of the fluorescence signal 
was performed using nigericin by the method of Thomas et al. [l 11. 
At the concentrations used dimethylsulfoxide, the solvent for delivery 
of FMLP, had no effect on pH,. 
2.4. Orher methods 
The activity of the NADPH-oxidase was measured in the presence 
of cytochalasin B (5 pg/ml) as the rate of oxygen consumption, as 
described earlier [12]. Results are presented as representative traces or 
as the mean f S.E. of the number of experiments indicated. Statistical 
comparisons were made using Student’s t-test for unpaired samples 
with a Bonferoni correction. 
3. RESULTS 
Recently, Bokoch and Prossnitz [13] demonstrated 
that treatment of HL-60 cells with lovastatin inhibited 
stimulation of the respiratory burst by chemoattrac- 
tants, suggesting that activation of the NADPH oxidase 
is mediated by isoprenylated GTP-binding proteins. To 
confirm the effectiveness of lovastatin in our experi- 
ments, the rate of FMLP-induced oxygen consumption 
was compared in control cells and in cells pretreated 
with the drug for 3 days. Lovastatin inhibited the che- 
moattractant-induced respiratory burst by 92.8%, con- 
sistent with the findings of Bokoch and Prossnitz [13]. 
This inhibition was entirely reversed by mevalonate. 
The mean pH, of differentiated HL-60 cells sus- 
pended in Na+-solution at 37°C was 7.17 & 0.01 (Table 
I), similar to values recorded in human neutrophils 
under comparable conditions [lo]. Pretreatment with 
lovastatin reduced resting pH, slightly, to 7.05 + 0.01 
(P < 0.01). This effect was reversed nearly completely 
by the addition of exogenous mevalonate (1 mM), the 
product of the pathway blocked by lovastatin (Table I). 
The reduction in the resting pH, is not due to complete 
obliteration of Na’/H+ exchange, since antiport activity 
could be readily elicited by osmotic stress or by treat- 
ment with chemotactic peptide (see below). 
As shown in Fig. lA, stimulation of the cells with 
FMLP induced a biphasic pH, change: an incipient acid- 
ification followed by a larger, sustained alkalosis. The 
latter is attributable to activation of the Na’/H’ an- 
tiporter, as it is eliminated by removal of external Na’ 
(not shown) or by addition of the potent amiloride ana- 
log MMPA (Fig. 1D). In the presence of MMPA, a 
sizeable acidification is unmasked, which has been ten- 
tatively attributed to generation of metabolic acid by 
the NADPH oxidase and/or the hexose monophosphate 
shunt [lo]. As shown in Fig. lE, this acidification is 
virtually eliminated by lovastatin, in parallel with inhi- 
bition of the respiratory burst. Moreover, this inhibition 
was bypassed by inclusion of mevalonate (Fig. 1 F), val- 
idating the specificity of the effect of lovastatin. These 
findings provide additional circumstantial evidence sup- 
porting the notion that metabolic acid generated by the 
respiratory burst is responsible for the drop in pH, trig- 
gered by FMLP. 
Inhibition of the metabolic acid burst by lovastatin 
was also apparent in the absence of MMPA (Fig. 1B). 
The small and rapid acidification noted in Fig. 1A was 
absent when isoprenylation was impaired (Fig. 1 B). De- 
spite the absence of the acidifying component, however, 
the rate and extent of the alkalinization mediated by 
Na+/H’ exchange were decreased after lovastatin treat- 
ment (cf. Fig. 1A and B). The maximal rate of alkalini- 
zation in response to FMLP decreased from 0.26 2 0.02 
to 0.15 ? 0.01 pH units/min (P < 0.001; Table I). As 
before, this effect of lovastatin was prevented by the 
concomitant addition of mevalonate. These findings 
suggest hat isoprenylation is at least partially required 
for activation of the antiporter by the chemoattractant- 
receptor complex. Failure of lovastatin to completely 
Table I 
Effect of lovastatin and mevalonate on pH, in resting and stimulated HL-60 cells 
Condition Resting pH, (n) Maximum rate of change of pH, (units/min) 
FMLP-stimulated (n) Osmotically-stimulated (n) 
Untreated 7.17 f 0.01 (18) 0.26 + 0.02 (7) 0.32 f 0.04 (6) 
Lovastatin 7.05 + 0.01 (21) 0.15 f 0.01 (9) 0.37 + 0.05 (6) 
Mevalonate 7.12 f 0.01 (9) 0.28 f 0.05 (3) 0.43 f 0.02 (3) 
Lovastatin + mevalonate 7.13 f 0.01 (11) 0.29 + 0.03 (4) 0.33 f 0.043 (4) 
Cells were loaded with BCECF and suspended in Na’-solution as described in section 2. The cells had been pretreated for 48 h without or with 
35 PM lovastatin or a mixture of 35 PM lovastatin and 1 mM mevalonate, as indicated. Where indicated, the cells were stimulated with 0.1 PM 
FMLP or by increasing the osmolarity with an additional 100 mM NaCl as in Figs. 1 and 2. The absolute pH, (first column) or the maximal rate 
of alkalinization (second and third columns) are shown. Values are the mean f S.E.M. of the number of determinations pecified (n). 
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In contrast to the findings in chemoattractant-treated 
cells, the cytoplasmic alkalinization induced by expos- 
ing cells to hypertonic medium (Fig. 2A) was not influ- 
enced by pretreatment with lovastatin or mevalonate 
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Fig. 1. Effects of lovastatin and mevalonate on the FMLP-induced pH, changes of HL-60 cells. Fluorimetric pH, determinations performed in cells 
suspended in Na’-solution in the absence (A-C) or presence of 1 PM MMPA (D-F). The cells had been pretreated for 48 h without (A and D) 
or with 35 PM lovastatin (B and E) or a mixture of 35 ,uM lovastatin and 1 mM mevalonate (C and F). Where indicated, the cells were stimulated 
with 0.1 PM FMLP. Traces are representative of at least three experiments of each type. 
(Fig. 2B). The rates of osmotically-induced alkaliniza- 
tion averaged 0.32 f 0.04 pH units/min and 0.37 f 0.05 
pH units/min in the absence and presence of lovastatin, 
respectively (Table I). These findings indicate that treat- 
ment with the drug did not directly interfere with the 
activity of the Na’/H’ antiporter. In addition, the data 
suggest hat different pathways mediate the stimulation 
of the antiport by receptors and by hypertonic shrinking. 
B 
lovastatin 
I I 
2 min 
6.6 
Fig. 2. Effects of lovastatin and mevalonate on the osmotically-induced alkalinization of HL-60 cells. (A) Cells suspended in isotonic Na’-medium 
were challenged where indicated by addition of concentrated NaCl (an additional 100 mM). MMPA (1 PM) was added to the bottom trace from 
the outset. (B) Cells were pretreated with lovastatin (lower trace) or a combination of lovastatin plus mevalonate as in Fig. 1 and suspended in 
isotonic Na+-medium. Where indicated, a hypertonic challenge was applied as in (A). Traces are representative of at least three experiments of 
each kind. 
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4. DISCUSSION 
Prenylation of some small molecular weight GTP- 
binding proteins and of G proteins is necessary for sig- 
nal transduction. This has been demonstrated primarily 
by using lovastatin. Thus, Vincent et al. [14], found that 
this drug impairs the progression from the Gl to the S 
phase of the cell cycle in cells stimulated by epidermal 
growth factor, insulin or insulin-like growth factor I. 
Similarly, lovastatin was reported to block 1,4,5-inosi- 
to1 triphosphate production, Ca2’ influx, secretion, and 
membrane changes in intact basophilic leukemia cells 
stimulated by IgE receptor cross-linking [15]. Also, as 
discussed above, Bokoch and Prossnitz demonstrated 
that activation of the phagocyte NADPH oxidase is 
lovastatin-sensitive [ 131. 
The involvement of a heterotrimeric G protein in the 
FMLP-induced stimulation of Na’/H’ exchange was 
established earlier by means of pertussis toxin [5]. It is 
noteworthy that this toxin completely eliminates timu- 
lation of the antiport. In contrast, under conditions 
where the respiratory burst and the associated meta- 
bolic acidosis are virtually eliminated, lovastatin only 
partially inhibits activation of Na’/H’ exchange (Table 
I). It is therefore unlikely that the effects of the isopre- 
nylation antagonist are exerted at the level of the hetero- 
trimeric G protein coupled to the chemoattractant re- 
ceptor. Instead, it is more likely that inhibition is due 
to impairment of a small GTP-binding protein. 
The data also suggest hat a second, lovastatin-insen- 
sitive pathway contributes to activation of the antiport. 
In contrast to the receptor-mediated response, the os- 
motic activation of the Na’/H’ antiporter remained un- 
affected by lovastatin. This finding implies divergence 
of the signalling pathways and suggests that isoprenyl- 
ated GTP-binding proteins are not required for the hy- 
pertonic effect. On the other hand, experiments using 
perfused barnacle muscles suggested earlier that GTP- 
binding proteins are involved in the osmotic activation 
of the antiporter [5]. Because some families of GTP- 
binding proteins are not isoprenylated, these data are 
not necessarily discordant. It is also possible that inver- 
tebrate cells utilize mechanisms different from those of 
mammals to promote Na’/H’ exchange. In this regard, 
it is relevant hat multiple isoforms of the antiport exist 
and that the trout exchanger, the only non-mammalian 
form studied to date, differs markedly in structure and 
properties from the mammalian isoforms [16]. 
Finally our data provide supportive evidence to the 
proposal that protons generated as a byproduct of the 
respiratory burst are the main cause of cytosolic acidifi- 
cation in stimulated granulocytes [lo]. Circumstantial 
evidence was provided by the pari passu inhibition of 
oxygen consumption and of the pH, drop observed in 
cells preincubated with lovastatin. 
In summary, the present results (a) point to the in- 
volvement of an isoprenylated protein in the activation 
of Na’/H’ exchange by chemoattractants, (b) reveal 
divergence of the receptor- and osmotically-induced 
stimulation of the antiport and (c) support the notion 
that the respiratory burst is responsible for cytosolic 
acidification during granulocyte activation. 
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